UPDATE: Targacept Announces will Discontinue TC-5214 Program, Cites Mixed Results
July 28, 2014 at 16:35 PM EDT
Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company advancing NNR Therapeutics™, today announced top-line results ...